Please provide your email address to receive an email when new articles are posted on . Glaucoma is the second leading cause of blindness in the U.S. A primary screening tool for glaucoma is ...
MedPage Today on MSN
Benefit of Dual Antiplatelet Therapy Murky in Valve-in-Valve Intervention
The interest in dual antiplatelet therapy after valve-in-valve transcatheter aortic valve intervention stems from the higher ...
GlobalData on MSN
FDA grants 510(k) clearance to Zenflow’s single-use cystoscope
The US Food and Drug Administration (FDA) has granted 510 (k) clearance to Zenflow’s Spring Scope and Camera Control Unit (CCU), a single-use cystoscope.
News-Medical.Net on MSN
Advances in nanomaterials revolutionize therapy for myocardial ischemia-reperfusion injury
Ischemic heart disease is the leading cause of death globally, causing approximately 9 million deaths annually.
The Healthy @Reader's Digest on MSN
Ketamine Therapy: A Medical Doctor Explains Its Use for Treatment-Resistant Depression
A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when other options fall short.
Recently, online sleuthing by concerned parents uncovered a discrepancy in the CDC’s language milestone trackers for children under age three, contradicting the milestone guidance set by the American ...
CHICAGO -- Early Intervention, a federal program dedicated to treating developmental delays in babies and toddlers and helping them develop the tools they need to thrive, is plagued by chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback